Bisphosphonates in Kidney Disease-Safety First

Affiliations

¹ Section of Nephrology, Baylor College of Medicine, Houston, TX, USA.
² Division of Nephrology, Columbia University Irving Medical Center, New York, NY, USA.

Editorial

Pascale Khairallah et al. J Bone Miner Res. 2021 May.

. 2021 May;36(5):817-819.

doi: 10.1002/jbmr.4283. Epub 2021 Apr 26.

¹ Section of Nephrology, Baylor College of Medicine, Houston, TX, USA.
² Division of Nephrology, Columbia University Irving Medical Center, New York, NY, USA.

No abstract available

Comment on

Safety of Oral Bisphosphonates in Moderate-to-Severe Chronic Kidney Disease: A Binational Cohort Analysis.
Robinson DE, Ali MS, Pallares N, Tebé C, Elhussein L, Abrahamsen B, Arden NK, Ben-Shlomo Y, Caskey FJ, Cooper C, Dedman D, Delmestri A, Judge A, Pérez-Sáez MJ, Pascual J, Nogues X, Diez-Perez A, Strauss VY, Javaid MK, Prieto-Alhambra D. Robinson DE, et al. J Bone Miner Res. 2021 May;36(5):820-832. doi: 10.1002/jbmr.4235. Epub 2021 Feb 8. J Bone Miner Res. 2021. PMID: 33373491

1. Bikbov B, Perico N, Remuzzi G; on behalf of the GBD Genitourinary Diseases Expert Group. Disparities in chronic kidney disease prevalence among males and females in 195 countries: analysis of the Global Burden of Disease 2016 study. Nephron. 2018;139(4):313-318.
1. GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709-733.
1. Nickolas TL, McMahon DJ, Shane E. Relationship between moderate to severe kidney disease and hip fracture in the United States. J Am Soc Nephrol. 2006;17(11):3223-3232.
1. Klawansky S, Komaroff E, Cavanaugh PF Jr, et al. Relationship between age, renal function and bone mineral density in the US population. Osteoporos Int. 2003;14(7):570-576.
1. Naylor KL, McArthur E, Leslie WD, et al. The three-year incidence of fracture in chronic kidney disease. Kidney Int. 2014;86(4):810-818.